Screener
IDEAYA Biosciences, Inc. IDYA Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.
The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206357
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 18,346 | 21,366 |
| Contract assets | 6,560 | 5,973 |
| Total current assets | 696,107 | 666,727 |
| Restricted cash | 1,281 | 1,015 |
| Long-term marketable securities | 301,713 | 410,297 |
| Property and equipment, net | 8,634 | 8,217 |
| Right-of-use assets | 22,613 | 23,068 |
| Total assets | $1,030,348 | $1,109,324 |
Item 1. Financial Statements (UNAUDITED).
FAQ
- What is IDEAYA Biosciences, Inc.'s restricted cash?
- IDEAYA Biosciences, Inc. (IDYA) reported restricted cash of $1.28M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s restricted cash changed year-over-year?
- IDEAYA Biosciences, Inc.'s restricted cash increased by 59.1% year-over-year, from $805K to $1.28M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s restricted cash?
- Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s restricted cash has grown at a 57.1% compound annual growth rate (CAGR), from $106K to $1.02M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about IDEAYA Biosciences, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude